Skip to content


Together, We Drive Results.

The synergy of collaboration with partners is helpful to support successful drug development, and we welcome strategic collaborations that speed the development of next generation treatments for those suffering from lysosomal storage disorders (LSDs).

If you are interested in utilizing our innovative S1S3 co-expression platform technology, developing next generation treatments for LSDs, or interested in learning more about collaboration and partnership opportunities, contact